---
title: Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy
date: '2022-05-20'
linkTitle: http://link.springer.com/10.1007/s11306-022-01879-7
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">As
  the most common chronic complication of diabetes mellitus (DM), diabetic peripheral
  neuropathy (DPN) seriously affects the quality of life of DM patients. So, it is
  of great significance for the diagnosis and treatment of DPN. In recent years, there
  have been numerous studies on pathogenesis and biomarkers of DM, but there are few
  studies on the biomarkers of DPN.</p> </span> <span class="a-plus-plus abstract-section
  id-a-sec2"> <h3 ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">As the most common chronic complication of diabetes mellitus (DM), diabetic peripheral neuropathy (DPN) seriously affects the quality of life of DM patients. So, it is of great significance for the diagnosis and treatment of DPN. In recent years, there have been numerous studies on pathogenesis and biomarkers of DM, but there are few studies on the biomarkers of DPN.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 ...